Vestmark Advisory Solutions, Inc. Bicycle Therapeutics PLC Transaction History

Vestmark Advisory Solutions, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$12.95 - $46.99 $128,282 - $465,482	-9,906 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$40.12 - $59.5 $6,298 - $9,341	157 Added 1.61%	9,906 $435,000
Q4 2021 Jan 31, 2022	SELL	$41.7 - $61.14 $5,337 - $7,825	-128 Reduced 1.3%	9,749 $593,000
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $4,975 - $7,874	-178 Reduced 1.77%	9,877 $411,000
Q2 2021 Aug 09, 2021	BUY	$27.0 - $32.28 $271,485 - $324,575	10,055 New	10,055 $305,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.